Skip to main content
. 2018 May 29;10(7):e8307. doi: 10.15252/emmm.201708307

Figure 7. AICAR and A‐769662 synergistically prevent cytokine‐induced myotube atrophy.

Figure 7

  1. Immunofluorescence staining for myoglobin and myosin heavy chain (MyHC) 48 h after treatment. Scale bars represent 50 μm. Quantification represents the average myotube width.
  2. Western blotting for iNOS and tubulin protein levels 24 h after treatment. Quantification represents the levels of iNOS protein normalized to tubulin and relative to the IFNγ/TNFα control.
  3. Western blotting of phospho‐Thr389‐p70S6K (pS6K), total p70S6K (S6K), phospho‐Ser235/236‐S6 (pS6), and total S6. Quantification represents the pS6K/S6K and pS6/S6 ratios relative to the NT control.
Data information: All quantifications are of three independent experiments (n = 3), and error bars represent the SEM. Significance between means was first determined using ANOVA. Significance P‐values were calculated using Fisher's LSD. *P < 0.05; **P < 0.01 from non‐treated (NT) controls; P < 0.05; †† P < 0.01 from IFNγ/TNFα‐treated controls.Source data are available online for this figure.